mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.09 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.09 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.09 |